Search research articles
Contact Us
Filters
Showing results (81-90 of 164) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma
Yasuhiro Oki, Hubert Chuang, Beth Chasen, et al.
Leukemia & Lymphoma
|
September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Bei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Blood
|
January 10, 2015
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Eric D Jacobsen, Jeff P Sharman, Yasuhiro Oki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes
Lanlan Shen, Hagop Kantarjian, Yi Guo, et al.
Haematologica
|
September 8, 2018
ABVD plus rituximab <i>versus</i> ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Paolo Strati, Michelle A Fanale, Yasuhiro Oki, et al.
Cancer
|
December 17, 2016
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation
Sarah A Milgrom, Shekeab Jauhari, John P Plastaras, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2014
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation
Bouthaina S Dabaja, Kenneth Hess, Ferial Shihadeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma
Yasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.
The Lancet. Oncology
|
July 22, 2014
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Anas Younes, Catherine Thieblemont, Franck Morschhauser, et al.
Blood
|
December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
Ian W Flinn, Susan O'Brien, Brad Kahl, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 164) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma
Yasuhiro Oki, Hubert Chuang, Beth Chasen, et al.
Leukemia & Lymphoma
|
September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Bei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Blood
|
January 10, 2015
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Eric D Jacobsen, Jeff P Sharman, Yasuhiro Oki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes
Lanlan Shen, Hagop Kantarjian, Yi Guo, et al.
Haematologica
|
September 8, 2018
ABVD plus rituximab <i>versus</i> ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Paolo Strati, Michelle A Fanale, Yasuhiro Oki, et al.
Cancer
|
December 17, 2016
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation
Sarah A Milgrom, Shekeab Jauhari, John P Plastaras, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2014
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation
Bouthaina S Dabaja, Kenneth Hess, Ferial Shihadeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma
Yasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.
The Lancet. Oncology
|
July 22, 2014
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Anas Younes, Catherine Thieblemont, Franck Morschhauser, et al.
Blood
|
December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
Ian W Flinn, Susan O'Brien, Brad Kahl, et al.
Page
of 17